Now, it’s worth noting Stock Advisor’s total average return is 991 % — a market-crushing outperformance compared to 196% for ...

Leerink raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $525 from $456 and keeps an Outperform rating on the shares. The firm cites an increase in its terminal growth assumption ...

As the United States market kicks off a holiday-shortened week with major stock indexes closing lower, investors are closely ...

Vertex Pharmaceuticals (VRTX) closed at $453.74 in the latest trading session, marking a -1.31% move from the prior day. This change lagged the S&P 500's daily loss of 0.14%. Meanwhile, the Dow ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...

Read here for Tweedy Browne's latest 13F updates, top holdings like Ionis Pharma, and shifting investment strategies.

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

According to Gartner, 58% of finance functions employed AI in 2024—a 21-percentage-point jump from the prior year. PwC ...

Learn how we built a WordPress plugin that uses vectors and LLMs to manage semantic internal linking directly inside the ...

Medical breakthroughs 2025 report highlights FDA approvals, gene therapies, and robotic telesurgery advancing patient care this year.

Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...